Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration - Exploratory, Multicenter, Randomized Clinical Trial

NCT03448887 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03448887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03448887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration - Exploratory, Multicenter, Randomized Clinical Trial
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2018
Completion date
August 31, 2020
Enrollment
80 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, chronic, renal dialysis